Abstract

The activation of signal transducer and activator of transcription 3 (Stat3) signaling is the common hallmark in various human cancers including osteosarcoma. In the present study, according to PCR-based microarrays using cDNA prepared from interleukin-6 (IL-6) treated osteosarcoma cells, we found that leucine-rich repeat-containing G protein-coupled receptor 4 (LGR4) was a transcriptional target of Stat3. Overexpression of Stat3 promoted LGR4 expression, while its deficiency using small interfering RNA (siRNA) reduced LGR4 expression. Furthermore, we identified a Stat3 binding motif located at −556 to −549 bp in the LGR4 promoter that is able to interact with Stat3. Thus, our results suggest a previously unknown Stat3-LGR4 molecular network, which may control osteosarcoma development and progression.

Highlights

  • Oncogenes and tumor suppressors play critical roles in the tumorigenesis [1]

  • We demonstrate that signal transducer and activator of transcription 3 (Stat3) regulates leucine-rich repeat-containing G protein-coupled receptor 4 (LGR4) expression in two human osteosarcoma cells

  • We identified a potential Stat3 binding site in the promoter region of LGR4 gene

Read more

Summary

Introduction

Oncogenes and tumor suppressors play critical roles in the tumorigenesis [1]. Signal transducer and activator of transcription 3 (Stat3) is a transcription factor that can promote tumor progression, and it is usually activated in several types of human cancer cells [2]. Stat signaling induced by its ligands such as interleukin-6, growth factors, is tightly regulated, owing to the existence of negative feedback mechanisms including induction of suppressor of cytokine signaling (SOCS) proteins [3]. In cancer cells, aberrant IL-6/Stat signaling has been implied as a critical mechanism for tumor initiation, proliferation, and metastasis [4, 5]. To better understand the roles of Stat it will be helpful to seek new therapeutics for human cancers including osteosarcoma

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call